Petrov, Konstantin A <br/><br/>
Specific inhibition of acetylcholinesterase as an approach to decrease muscarinic side effects during myasthenia gravis treatment.  [electronic resource] 

 -  Scientific reports  01 2018 
 - 304 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-017-18307-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cholinesterase Inhibitors--adverse effects<br/>Humans<br/>Intestines--drug effects<br/>Muscle Contraction<br/>Muscle, Smooth--drug effects<br/>Myasthenia Gravis, Autoimmune, Experimental--drug therapy<br/>Pyridostigmine Bromide--adverse effects<br/>Quaternary Ammonium Compounds--adverse effects<br/>Rats<br/>Uracil--adverse effects<br/>Urinary Bladder--drug effects